HS90A_MOUSE - dbPTM
HS90A_MOUSE - PTM Information in dbPTM
Basic Information of Protein
UniProt ID HS90A_MOUSE
UniProt AC P07901
Protein Name Heat shock protein HSP 90-alpha
Gene Name Hsp90aa1
Organism Mus musculus (Mouse).
Sequence Length 733
Subcellular Localization Nucleus . Cytoplasm . Melanosome . Cell membrane .
Protein Description Molecular chaperone that promotes the maturation, structural maintenance and proper regulation of specific target proteins involved for instance in cell cycle control and signal transduction. Undergoes a functional cycle that is linked to its ATPase activity which is essential for its chaperone activity. This cycle probably induces conformational changes in the client proteins, thereby causing their activation. Interacts dynamically with various co-chaperones that modulate its substrate recognition, ATPase cycle and chaperone function. Engages with a range of client protein classes via its interaction with various co-chaperone proteins or complexes, that act as adapters, simultaneously able to interact with the specific client and the central chaperone itself. Recruitment of ATP and co-chaperone followed by client protein forms a functional chaperone. After the completion of the chaperoning process, properly folded client protein and co-chaperone leave HSP90 in an ADP-bound partially open conformation and finally, ADP is released from HSP90 which acquires an open conformation for the next cycle. Apart from its chaperone activity, it also plays a role in the regulation of the transcription machinery. HSP90 and its co-chaperones modulate transcription at least at three different levels. In the first place, they alter the steady-state levels of certain transcription factors in response to various physiological cues. Second, they modulate the activity of certain epigenetic modifiers, such as histone deacetylases or DNA methyl transferases, and thereby respond to the change in the environment. Third, they participate in the eviction of histones from the promoter region of certain genes and thereby turn on gene expression. Binds bacterial lipopolysaccharide (LPS) and mediates LPS-induced inflammatory response, including TNF secretion by monocytes. Antagonizes STUB1-mediated inhibition of TGF-beta signaling via inhibition of STUB1-mediated SMAD3 ubiquitination and degradation..
Protein Sequence MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPSKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAEEKEEKEEEKEKEEKESDDKPEIEDVGSDEEEEEKKDGDKKKKKKIKEKYIDQEELNKTKPIWTRNPDDITNEEYGEFYKSLTNDWEEHLAVKHFSVEGQLEFRALLFVPRRAPFDLFENRKKKNNIKLYVRRVFIMDNCEELIPEYLNFIRGVVDSEDLPLNISREMLQQSKILKVIRKNLVKKCLELFTELAEDKENYKKFYEQFSKNIKLGIHEDSQNRKKLSELLRYYTSASGDEMVSLKDYCTRMKENQKHIYFITGETKDQVANSAFVERLRKHGLEVIYMIEPIDEYCVQQLKEFEGKTLVSVTKEGLELPEDEEEKKKQEEKKTKFENLCKIMKDILEKKVEKVVVSNRLVTSPCCIVTSTYGWTANMERIMKAQALRDNSTMGYMAAKKHLEINPDHSIIETLRQKAEADKNDKSVKDLVILLYETALLSSGFSLEDPQTHANRIYRMIKLGLGIDEDDPTVDDTSAAVTEEMPPLEGDDDTSRMEEVD
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
5Phosphorylation---MPEETQTQDQPM
---CCCCCCCCCCCC
34.942507541
7Phosphorylation-MPEETQTQDQPMEE
-CCCCCCCCCCCCCH
41.342507541
38PhosphorylationSLIINTFYSNKEIFL
HHHHHHHCCCHHHHH
14.86-
41AcetylationINTFYSNKEIFLREL
HHHHCCCHHHHHHHH
46.3722826441
41SuccinylationINTFYSNKEIFLREL
HHHHCCCHHHHHHHH
46.3723954790
52PhosphorylationLRELISNSSDALDKI
HHHHHHCCCHHHHHH
23.8622817900
53PhosphorylationRELISNSSDALDKIR
HHHHHCCCHHHHHHC
31.0219854140
58AcetylationNSSDALDKIRYESLT
CCCHHHHHHCHHHCC
29.9023806337
58UbiquitinationNSSDALDKIRYESLT
CCCHHHHHHCHHHCC
29.9022790023
61PhosphorylationDALDKIRYESLTDPS
HHHHHHCHHHCCCHH
17.2222817900
63PhosphorylationLDKIRYESLTDPSKL
HHHHCHHHCCCHHHC
27.8624899341
65PhosphorylationKIRYESLTDPSKLDS
HHCHHHCCCHHHCCC
55.9621183079
68PhosphorylationYESLTDPSKLDSGKE
HHHCCCHHHCCCCCE
48.9721183079
69AcetylationESLTDPSKLDSGKEL
HHCCCHHHCCCCCEE
62.8023806337
69UbiquitinationESLTDPSKLDSGKEL
HHCCCHHHCCCCCEE
62.8022790023
72PhosphorylationTDPSKLDSGKELHIN
CCHHHCCCCCEEEEE
63.3026370283
74UbiquitinationPSKLDSGKELHINLI
HHHCCCCCEEEEEEC
62.1422790023
84AcetylationHINLIPSKQDRTLTI
EEEECCCCCCCEEEE
51.3623806337
84UbiquitinationHINLIPSKQDRTLTI
EEEECCCCCCCEEEE
51.3622790023
90PhosphorylationSKQDRTLTIVDTGIG
CCCCCEEEEEECCCC
20.5222006019
98SulfoxidationIVDTGIGMTKADLIN
EEECCCCCCHHHHHH
3.0821406390
99PhosphorylationVDTGIGMTKADLINN
EECCCCCCHHHHHHH
20.19-
100UbiquitinationDTGIGMTKADLINNL
ECCCCCCHHHHHHHH
30.89-
109PhosphorylationDLINNLGTIAKSGTK
HHHHHHHHHHHHHHH
22.4129514104
112AcetylationNNLGTIAKSGTKAFM
HHHHHHHHHHHHHHH
45.6423806337
112SuccinylationNNLGTIAKSGTKAFM
HHHHHHHHHHHHHHH
45.6423806337
112UbiquitinationNNLGTIAKSGTKAFM
HHHHHHHHHHHHHHH
45.64-
116UbiquitinationTIAKSGTKAFMEALQ
HHHHHHHHHHHHHHH
43.05-
160PhosphorylationKHNDDEQYAWESSAG
CCCCCCCEEEECCCC
16.1925168779
164PhosphorylationDEQYAWESSAGGSFT
CCCEEEECCCCCEEE
18.1326525534
165PhosphorylationEQYAWESSAGGSFTV
CCEEEECCCCCEEEE
21.2926525534
169PhosphorylationWESSAGGSFTVRTDT
EECCCCCEEEEEECC
19.4725168779
171PhosphorylationSSAGGSFTVRTDTGE
CCCCCEEEEEECCCC
15.6925168779
185UbiquitinationEPMGRGTKVILHLKE
CCCCCCEEEEEEECC
30.06-
191AcetylationTKVILHLKEDQTEYL
EEEEEEECCCHHHHH
48.8022826441
191UbiquitinationTKVILHLKEDQTEYL
EEEEEEECCCHHHHH
48.80-
195PhosphorylationLHLKEDQTEYLEERR
EEECCCHHHHHHHHH
38.6328066266
197PhosphorylationLKEDQTEYLEERRIK
ECCCHHHHHHHHHHH
23.8522817900
204AcetylationYLEERRIKEIVKKHS
HHHHHHHHHHHHHHH
39.3123576753
208AcetylationRRIKEIVKKHSQFIG
HHHHHHHHHHHHHCC
50.8923576753
209AcetylationRIKEIVKKHSQFIGY
HHHHHHHHHHHHCCC
37.2823576753
211PhosphorylationKEIVKKHSQFIGYPI
HHHHHHHHHHCCCCE
35.3527841257
224AcetylationPITLFVEKERDKEVS
CEEEEEEHHHCCCCC
53.3922826441
224UbiquitinationPITLFVEKERDKEVS
CEEEEEEHHHCCCCC
53.3922790023
231PhosphorylationKERDKEVSDDEAEEK
HHHCCCCCHHHHHHH
40.2027087446
252PhosphorylationKEKEEKESDDKPEIE
HHHHHHHCCCCCCCC
63.2825521595
263PhosphorylationPEIEDVGSDEEEEEK
CCCCCCCCCHHHHHH
41.5224925903
275AcetylationEEKKDGDKKKKKKIK
HHHCCCCHHHHHHHH
72.527719459
275MalonylationEEKKDGDKKKKKKIK
HHHCCCCHHHHHHHH
72.5226320211
276AcetylationEKKDGDKKKKKKIKE
HHCCCCHHHHHHHHH
74.667719473
282MalonylationKKKKKKIKEKYIDQE
HHHHHHHHHHHCCHH
57.9726320211
284AcetylationKKKKIKEKYIDQEEL
HHHHHHHHHCCHHHH
42.3769965
284MalonylationKKKKIKEKYIDQEEL
HHHHHHHHHCCHHHH
42.3726320211
284UbiquitinationKKKKIKEKYIDQEEL
HHHHHHHHHCCHHHH
42.37-
285PhosphorylationKKKIKEKYIDQEELN
HHHHHHHHCCHHHHH
15.7225159016
293AcetylationIDQEELNKTKPIWTR
CCHHHHHCCCCCCCC
71.2322826441
293MalonylationIDQEELNKTKPIWTR
CCHHHHHCCCCCCCC
71.2326320211
293SuccinylationIDQEELNKTKPIWTR
CCHHHHHCCCCCCCC
71.2323806337
293UbiquitinationIDQEELNKTKPIWTR
CCHHHHHCCCCCCCC
71.23-
294PhosphorylationDQEELNKTKPIWTRN
CHHHHHCCCCCCCCC
40.7627600695
295AcetylationQEELNKTKPIWTRNP
HHHHHCCCCCCCCCC
35.79183491
295UbiquitinationQEELNKTKPIWTRNP
HHHHHCCCCCCCCCC
35.7922790023
314PhosphorylationNEEYGEFYKSLTNDW
HHHHHHHHHHHCCCH
8.7222817900
315AcetylationEEYGEFYKSLTNDWE
HHHHHHHHHHCCCHH
44.2923954790
315UbiquitinationEEYGEFYKSLTNDWE
HHHHHHHHHHCCCHH
44.29-
316PhosphorylationEYGEFYKSLTNDWEE
HHHHHHHHHCCCHHH
29.1026745281
318PhosphorylationGEFYKSLTNDWEEHL
HHHHHHHCCCHHHHE
37.9226745281
363UbiquitinationRKKKNNIKLYVRRVF
CCCCCCCEEEEEEEE
35.57-
375GlutathionylationRVFIMDNCEELIPEY
EEECCCCHHHHHHHH
3.6124333276
375S-palmitoylationRVFIMDNCEELIPEY
EEECCCCHHHHHHHH
3.6128526873
392PhosphorylationFIRGVVDSEDLPLNI
HHHCCCCCCCCCCCC
22.7726525534
400PhosphorylationEDLPLNISREMLQQS
CCCCCCCCHHHHHHH
22.5527742792
407PhosphorylationSREMLQQSKILKVIR
CHHHHHHHHHHHHHH
14.5426745281
408AcetylationREMLQQSKILKVIRK
HHHHHHHHHHHHHHH
47.9522826441
408MalonylationREMLQQSKILKVIRK
HHHHHHHHHHHHHHH
47.9526320211
408SuccinylationREMLQQSKILKVIRK
HHHHHHHHHHHHHHH
47.9523806337
408UbiquitinationREMLQQSKILKVIRK
HHHHHHHHHHHHHHH
47.95-
411AcetylationLQQSKILKVIRKNLV
HHHHHHHHHHHHHHH
38.8022826441
411MalonylationLQQSKILKVIRKNLV
HHHHHHHHHHHHHHH
38.8025418362
420UbiquitinationIRKNLVKKCLELFTE
HHHHHHHHHHHHHHH
36.2522790023
432AcetylationFTELAEDKENYKKFY
HHHHHHCHHHHHHHH
39.09155729
432UbiquitinationFTELAEDKENYKKFY
HHHHHHCHHHHHHHH
39.09-
436AcetylationAEDKENYKKFYEQFS
HHCHHHHHHHHHHHH
48.24129217
437AcetylationEDKENYKKFYEQFSK
HCHHHHHHHHHHHHH
42.7023806337
437MalonylationEDKENYKKFYEQFSK
HCHHHHHHHHHHHHH
42.7026320211
437SuccinylationEDKENYKKFYEQFSK
HCHHHHHHHHHHHHH
42.70-
437UbiquitinationEDKENYKKFYEQFSK
HCHHHHHHHHHHHHH
42.70-
443PhosphorylationKKFYEQFSKNIKLGI
HHHHHHHHHHCCCCC
25.2022006019
444AcetylationKFYEQFSKNIKLGIH
HHHHHHHHHCCCCCC
65.0723236377
444UbiquitinationKFYEQFSKNIKLGIH
HHHHHHHHHCCCCCC
65.0722790023
454PhosphorylationKLGIHEDSQNRKKLS
CCCCCCCCHHHHHHH
26.7726824392
459AcetylationEDSQNRKKLSELLRY
CCCHHHHHHHHHHHH
54.7522826441
461O-linked_GlycosylationSQNRKKLSELLRYYT
CHHHHHHHHHHHHHH
34.7721540332
461PhosphorylationSQNRKKLSELLRYYT
CHHHHHHHHHHHHHH
34.77-
466PhosphorylationKLSELLRYYTSASGD
HHHHHHHHHHCCCCC
15.8627149854
467PhosphorylationLSELLRYYTSASGDE
HHHHHHHHHCCCCCC
6.4427149854
468PhosphorylationSELLRYYTSASGDEM
HHHHHHHHCCCCCCC
14.6427149854
469PhosphorylationELLRYYTSASGDEMV
HHHHHHHCCCCCCCE
12.3323984901
471PhosphorylationLRYYTSASGDEMVSL
HHHHHCCCCCCCEEH
46.6926239621
477PhosphorylationASGDEMVSLKDYCTR
CCCCCCEEHHHHHHH
28.5227149854
479AcetylationGDEMVSLKDYCTRMK
CCCCEEHHHHHHHHH
38.8622826441
479UbiquitinationGDEMVSLKDYCTRMK
CCCCEEHHHHHHHHH
38.8622790023
482S-palmitoylationMVSLKDYCTRMKENQ
CEEHHHHHHHHHHHC
2.5228680068
483PhosphorylationVSLKDYCTRMKENQK
EEHHHHHHHHHHHCC
27.8021183079
486AcetylationKDYCTRMKENQKHIY
HHHHHHHHHHCCEEE
50.6622826441
490AcetylationTRMKENQKHIYFITG
HHHHHHCCEEEEEEC
43.4822826441
493PhosphorylationKENQKHIYFITGETK
HHHCCEEEEEECCCH
6.6618779572
496PhosphorylationQKHIYFITGETKDQV
CCEEEEEECCCHHHH
21.0418779572
499PhosphorylationIYFITGETKDQVANS
EEEEECCCHHHHHHH
41.0622345495
500AcetylationYFITGETKDQVANSA
EEEECCCHHHHHHHH
41.6922826441
506PhosphorylationTKDQVANSAFVERLR
CHHHHHHHHHHHHHH
17.2222006019
514AcetylationAFVERLRKHGLEVIY
HHHHHHHHCCCEEEE
46.7622826441
529PhosphorylationMIEPIDEYCVQQLKE
EECCCCHHHHHHHHH
8.3222817900
540AcetylationQLKEFEGKTLVSVTK
HHHHCCCCEEEEEEH
31.3323806337
540SuccinylationQLKEFEGKTLVSVTK
HHHHCCCCEEEEEEH
31.3323954790
540UbiquitinationQLKEFEGKTLVSVTK
HHHHCCCCEEEEEEH
31.33-
547AcetylationKTLVSVTKEGLELPE
CEEEEEEHHCCCCCC
47.8622826441
547SuccinylationKTLVSVTKEGLELPE
CEEEEEEHHCCCCCC
47.8623954790
547UbiquitinationKTLVSVTKEGLELPE
CEEEEEEHHCCCCCC
47.86-
559AcetylationLPEDEEEKKKQEEKK
CCCCHHHHHHHHHHH
69.4223236377
559UbiquitinationLPEDEEEKKKQEEKK
CCCCHHHHHHHHHHH
69.42-
561UbiquitinationEDEEEKKKQEEKKTK
CCHHHHHHHHHHHHH
74.20-
566AcetylationKKKQEEKKTKFENLC
HHHHHHHHHHHHHHH
61.2922826441
567PhosphorylationKKQEEKKTKFENLCK
HHHHHHHHHHHHHHH
52.6222817900
568AcetylationKQEEKKTKFENLCKI
HHHHHHHHHHHHHHH
60.6122826441
568UbiquitinationKQEEKKTKFENLCKI
HHHHHHHHHHHHHHH
60.61-
573S-nitrosylationKTKFENLCKIMKDIL
HHHHHHHHHHHHHHH
4.1824926564
577AcetylationENLCKIMKDILEKKV
HHHHHHHHHHHHHHC
45.1223236377
582UbiquitinationIMKDILEKKVEKVVV
HHHHHHHHHCCEEEE
59.69-
583AcetylationMKDILEKKVEKVVVS
HHHHHHHHCCEEEEC
46.3722826441
586AcetylationILEKKVEKVVVSNRL
HHHHHCCEEEECCCC
43.2322826441
586MalonylationILEKKVEKVVVSNRL
HHHHHCCEEEECCCC
43.2326320211
586UbiquitinationILEKKVEKVVVSNRL
HHHHHCCEEEECCCC
43.23-
595PhosphorylationVVSNRLVTSPCCIVT
EECCCCCCCCEEEEE
31.3826745281
596PhosphorylationVSNRLVTSPCCIVTS
ECCCCCCCCEEEEEE
14.4125266776
598GlutathionylationNRLVTSPCCIVTSTY
CCCCCCCEEEEEECC
2.1824333276
598S-palmitoylationNRLVTSPCCIVTSTY
CCCCCCCEEEEEECC
2.1828680068
599S-nitrosocysteineRLVTSPCCIVTSTYG
CCCCCCEEEEEECCC
2.96-
599GlutathionylationRLVTSPCCIVTSTYG
CCCCCCEEEEEECCC
2.9624333276
599S-nitrosylationRLVTSPCCIVTSTYG
CCCCCCEEEEEECCC
2.96-
602PhosphorylationTSPCCIVTSTYGWTA
CCCEEEEEECCCCHH
8.7423984901
603PhosphorylationSPCCIVTSTYGWTAN
CCEEEEEECCCCHHC
14.5623984901
604PhosphorylationPCCIVTSTYGWTANM
CEEEEEECCCCHHCH
19.3823984901
605PhosphorylationCCIVTSTYGWTANME
EEEEEECCCCHHCHH
15.5020116462
608PhosphorylationVTSTYGWTANMERIM
EEECCCCHHCHHHHH
12.0925777480
616AcetylationANMERIMKAQALRDN
HCHHHHHHHHHHHCC
34.6723806337
616MethylationANMERIMKAQALRDN
HCHHHHHHHHHHHCC
34.67-
616SuccinylationANMERIMKAQALRDN
HCHHHHHHHHHHHCC
34.6723806337
616UbiquitinationANMERIMKAQALRDN
HCHHHHHHHHHHHCC
34.67-
624PhosphorylationAQALRDNSTMGYMAA
HHHHHCCCHHHHHHH
24.8627841257
625PhosphorylationQALRDNSTMGYMAAK
HHHHCCCHHHHHHHH
22.3722006019
628PhosphorylationRDNSTMGYMAAKKHL
HCCCHHHHHHHHHHC
3.4629899451
632AcetylationTMGYMAAKKHLEINP
HHHHHHHHHHCCCCC
31.0523806337
632MalonylationTMGYMAAKKHLEINP
HHHHHHHHHHCCCCC
31.0526320211
632SuccinylationTMGYMAAKKHLEINP
HHHHHHHHHHCCCCC
31.05-
632UbiquitinationTMGYMAAKKHLEINP
HHHHHHHHHHCCCCC
31.05-
633AcetylationMGYMAAKKHLEINPD
HHHHHHHHHCCCCCC
49.0123806337
633UbiquitinationMGYMAAKKHLEINPD
HHHHHHHHHCCCCCC
49.0122790023
642PhosphorylationLEINPDHSIIETLRQ
CCCCCCCHHHHHHHH
32.4225521595
646PhosphorylationPDHSIIETLRQKAEA
CCCHHHHHHHHHHHH
19.4826745281
655AcetylationRQKAEADKNDKSVKD
HHHHHHCCCCCCHHH
74.2723864654
705PhosphorylationGIDEDDPTVDDTSAA
CCCCCCCCCCCCCCC
43.4925777480
709PhosphorylationDDPTVDDTSAAVTEE
CCCCCCCCCCCCCCC
18.7925777480
710PhosphorylationDPTVDDTSAAVTEEM
CCCCCCCCCCCCCCC
22.6425777480
714PhosphorylationDDTSAAVTEEMPPLE
CCCCCCCCCCCCCCC
22.8525777480
726PhosphorylationPLEGDDDTSRMEEVD
CCCCCCCCCCCCCCC
25.8121183079
727PhosphorylationLEGDDDTSRMEEVD-
CCCCCCCCCCCCCC-
36.3019060867

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
5TPhosphorylationKinasePRKDCP97313
Uniprot
7TPhosphorylationKinasePRKDCP97313
Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of HS90A_MOUSE !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of HS90A_MOUSE !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
CDC37_MOUSECdc37physical
17189825
CHRD1_MOUSEChordc1physical
23184943
CDK4_MOUSECdk4physical
11867521
IMB1_MOUSEKpnb1physical
19581287
NUP62_MOUSENup62physical
19581287

Drug and Disease Associations
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of HS90A_MOUSE

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Solid tumor proteome and phosphoproteome analysis by high resolutionmass spectrometry.";
Zanivan S., Gnad F., Wickstroem S.A., Geiger T., Macek B., Cox J.,Faessler R., Mann M.;
J. Proteome Res. 7:5314-5326(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-231 AND SER-263, ANDMASS SPECTROMETRY.
"Mitochondrial phosphoproteome revealed by an improved IMAC method andMS/MS/MS.";
Lee J., Xu Y., Chen Y., Sprung R., Kim S.C., Xie S., Zhao Y.;
Mol. Cell. Proteomics 6:669-676(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-231, AND MASSSPECTROMETRY.
"Protein phosphorylation and expression profiling by Yin-yangmultidimensional liquid chromatography (Yin-yang MDLC) massspectrometry.";
Dai J., Jin W.-H., Sheng Q.-H., Shieh C.-H., Wu J.-R., Zeng R.;
J. Proteome Res. 6:250-262(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-263, AND MASSSPECTROMETRY.
"Specific phosphopeptide enrichment with immobilized titanium ionaffinity chromatography adsorbent for phosphoproteome analysis.";
Zhou H., Ye M., Dong J., Han G., Jiang X., Wu R., Zou H.;
J. Proteome Res. 7:3957-3967(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-231 AND SER-263, ANDMASS SPECTROMETRY.
"Large-scale identification and evolution indexing of tyrosinephosphorylation sites from murine brain.";
Ballif B.A., Carey G.R., Sunyaev S.R., Gygi S.P.;
J. Proteome Res. 7:311-318(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-314, AND MASSSPECTROMETRY.
"Quantitative time-resolved phosphoproteomic analysis of mast cellsignaling.";
Cao L., Yu K., Banh C., Nguyen V., Ritz A., Raphael B.J., Kawakami Y.,Kawakami T., Salomon A.R.;
J. Immunol. 179:5864-5876(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-493, AND MASSSPECTROMETRY.

TOP